NCT02653118View on ClinicalTrials.gov

Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)

Active, not recruitingOBSERVATIONAL
Enrollment

4,453

Participants

Timeline

Start Date

January 22, 2016

Primary Completion Date

January 1, 2040

Study Completion Date

January 1, 2040

Conditions
Cervical CancerVulvar CancerVaginal CancerGenital WartsHuman Papillomavirus Infection
Interventions
BIOLOGICAL

V503

BIOLOGICAL

GARDASIL

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT02653118 - Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) | Biotech Hunter | Biotech Hunter